Brind.

Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.

2 reports, 2 independent Updated Oct 29
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Molecular Partners, led by Patrick Amstutz, announced a partnership with Novartis.1 source
  2. Molecular Partners appoints Patrick Amstutz as CEO; details of Martin Steegmaier's career path are revealed.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • jobsnhire.com
  • GlobeNewswireMolecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics Extensive experience from senior oncology research roles at Roche, MorphoS